Pyrimidine and fused pyrimidine derivatives as promising protein kinase inhibitors for cancer treatment
Crossref DOI link: https://doi.org/10.1007/s00044-020-02656-8
Published Online: 2020-10-29
Published Print: 2021-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abdellatif, Khaled R. A.
Bakr, Rania B.
Text and Data Mining valid from 2020-10-29
Version of Record valid from 2020-10-29
Article History
Received: 9 July 2020
Accepted: 17 October 2020
First Online: 29 October 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.